WO2006050734A3
(en )
2006-08-03
Potent lna oligonucleotides for the inhibition of hif-1a expression
HK1244504A1
(zh )
2018-08-10
反義設計
IL176320A0
(en )
2006-10-05
Oligomeric compounds for the modulation of bcl-2
WO2004009769A3
(en )
2006-04-13
COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
WO2003100017A3
(en )
2004-08-26
Oligonucleotides having modified nucleoside units
IL300119A
(en )
2023-03-01
Oligonucleotides to induce paternal UBE3A expression
EP2213736A3
(de )
2010-09-01
Verfahren zur Hemmung der Expression eines Zielgens und Medikament zur Therapie einer Tumorerkrankung
DE69934227D1
(de )
2007-01-11
Auf beta-arabinose, und dessen analogen, basierte antisense oligonukleotide
WO2009017803A8
(en )
2009-08-06
Antisense microrna and uses therefor
EP1750771A4
(en )
2007-11-07
PANCREATIC ILOT MICRO-RNA AND METHODS OF INHIBITING THE SAME
WO2004065546A3
(en )
2006-03-23
COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ICAM-1
WO2004044139A3
(en )
2005-02-10
Modified oligonucleotides for use in rna interference
WO2004094606A3
(en )
2005-09-15
COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2
WO2001032832A3
(en )
2001-10-18
Antisense inhibition of nucleolin expression
MX2020009765A
(es )
2021-01-08
Oligonucleotido antisentido reducido en toxicidad.
AU2014208251B2
(en )
2016-07-14
Carbohydrate conjugates as delivery agents for oligonucleotides
WO2007117121A3
(en )
2007-12-27
Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent
HK1113318A1
(en )
2008-10-03
Oligonucleotide and compositions comprising the same for treating b cell neoplasm
MX2021007932A
(es )
2021-08-16
Molecula oligomerica de acido nucleico y uso de esta.
UA93188C2
(ru )
2011-01-25
Эффективные олигонуклеотиды lna для ингибирования экспрессии hif-1a
WO2008001219A3
(en )
2008-05-08
Cancer therapy using bcl-xl-specific sina
Peyman et al.
1997
Nuclease stability as dominant factor in the antiviral activity of oligonucleotides directed against HSV-1 IE110
DE10346721A1
(de )
2005-05-04
Oligonukleotide, diese enthaltende Mittel und deren Verwendung
Rivory et al.
2006
The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity
ATE428786T1
(de )
2009-05-15
Antisense-oligonukleotid mit antikrebsaktivität